Donation of blood is associated with reduced risk of myocardial infarction: The Kuopio Ischaemic Heart Disease Risk Factor Study

American Journal of Epidemiology

Volumn 148, Issue 5, 1998, Pages 445-451

  Salonen, Jukka T ^a   Tuomainen, Tomi Pekka ^a   Salonen, Riitta ^a   Lakka, Timo A ^b   Nyyssönen, Kristiina ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cardiovascular diseases; Iron; Myocardial infarction; Population studies; Risk factors

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR;

EID: 0032167670     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009669     Document Type: Article

References (50)

1. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4.
2. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol 1983;117:165-72.
3. Gordon T, Kannel WB, Hjortland MC, et al. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978;89:157-61.
4. Centerwall BS. Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol 1981;139:58-61.
5. Gutteridge JM, Halliwell B. Iron toxicity and oxygen radicals. Baillieres Clin Haematol 1989;2:195-256.
6. Agil A, Fuller CJ, Jialal I. Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction. Clin Chem 1995;41:220-5.
7. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995;18:321-36.
8. Salonen JT, Nyyssönen K, Korpela H, et al. High stored on levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
9. Salonen JT, Nyyssönen K, Salonen R. Body iron stores and the risk of coronary heart disease. (Letter). N Engl J Med 1994;331:1159.
10. Salonen JT. The role of iron as a cardiovascular risk factor. Curr Opinion Lipidol 1993; 4: 277-82.
11. Salonen JT. Body iron stores, lipid peroxidation and coronary heart disease. In: Hallberg L, Asp N-G, eds. Iron nutrition in health and disease. London: JL London Press, 1996:293-301.
12. Balla G, Jacob HS, Eaton JW, et al. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 1991;11:1700-11.
13. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-27.
14. Weiner MA, Paige SB, Bailey SR. Antioxidant therapy decreases atherosclerotic plaque burden in an iron loaded animal model. Eur Heart J 1994;425(Suppl 15):2241.
15. Araujo JA, Romano EL, Brito BE, et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 1995;15:1172-80.
16. Smith C, Mitchinson MJ, Aruoma OI, et al. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 1992;286: 901-5.
17. Swain J, Gutteridge JM. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett 1995;368:513-15.
18. Ascherio A, Willett WC. New directions in dietary studies of coronary heart disease. J Nutr 1995;125(Suppl 3):647S-655S
19. Sempos CT, Looker AC, Gillum RF. Iron and heart disease: the epidemiologic data. Nutr Rev 1996;54:73-84.
20. Corti MC, Gaziano M, Hennekens CH. Iron status and risk of cardiovascular diseases. Ann Epidemiol 1997;7:62-8.
21. Morrison HI, Semenciw RM, Mao Y, et al. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 1994; 5:243-6.
22. Baer DM, Tekawa IS, Hurley LB. Iron stores are not associated with acute myocardial infarction. Circulation 1994;89: 2915-18.
23. Sempos CT, Looker AC, Gillum RF, et al. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 330:1119-24.
24. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: negative findings from the NHANES I Epidemiologic Follow-up study. Am J Epidemiol 1994;139:704-12.
25. Reunanen A, Takkunen H, Knekt P, et al. Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med 1995;238:223-30.
26. Van Asperen IA, Feskens EJ, Bowles CH, et al. Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women. Int J Epidemiol 1995;24:665-70.
27. Tuomainen T-P, Salonen R, Nyyssönen K, et al. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. Br Med J 1997; 314:793-4.
28. Meyers DG, Strickland D, Maloney PA, et al. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997;78:188-93.
29. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Study. Ann Clin Res 1988;20:46-50.
30. Keys A. Seven countries: a multivariate analysis of death coronary heart disease. Boston, MA: Harvard University Press, 1980.
31. Salonen JT, Salonen R, Seppänen K, et al. HDL, HDL2, and HDL3 subfractions and the risk of acute myocardial infarction. Circulation 1991;84:129-39.
32. Lakka TA, Venäläinen JM, Rauramaa R, et al. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994;330:1549-54.
33. Wilson TW, Kaplan GA, Kauhanen J, et al. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol 1993;137:292-300.
34. Salonen JT, Seppänen K, Nyyssönen K, et al. Intake of mercury from fish, lipid peroxidation and the risk of myocardial infarction and coronary, cardiovascular and any death in Eastern Finnish men. Circulation 1995;91:645-55.
35. Nyyssönen K, Parviainen MT, Salonen R, et al. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. Brit Med J 1997; 314:634-8.
36. Lynch JW, Kaplan GA, Cohen RD, et al. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol 1996;144:934-42.
37. Lynch JW, Kaplan GA, Salonen JT. Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic life-course. Soc Sci Med 1997;44:809-19.
38. Everson SA, Kauhanen J, Kaplan GA, et al. Hostility and increased risk of mortality and acute myocardial infarction: the mediating role of behavioral risk factors. Am J Epidemiol 1997;146:142-52.
39. Ihanainen M, Salonen R, Seppänen R, et al. Nutrition data collection in the Kuopio Ischaemic Heart Disease Risk Factor Study: nutrient intake of middle-aged Eastern Finnish men. Nutr Res 1989;9:597-604.
40. Rose GA, Blackburn H, Gillum RF, et al. Cardiovascular survey methods. Geneva: World Health Organization, 162-5.
41. Tuomilehto J, Kuulasmaa K. WHO Monica Project: assessing CHD mortality and morbidity. Int J Epidemiol 1989;18(Suppl 1):38S-45S.
42. Selvin S. Statistical analysis of epidemiologic data. New York: Oxford University Press, 1991.
43. Tuomainen T-P, Punnonen K, Nyyssönen K, et al. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;99:1761-6.
44. Ascherio A, Willett WC, Rimm EB, et al. Dietary iron intake and risk of coronary disease among men. Circulation 1994; 89:969-74.
45. Erikssen G, Thaulow E, Sandvik L, et al. Haematocrit: a predictor of cardiovascular mortality? J Intern Med 1993;234: 493-9.
46. Wannamethee G, Shaper AG, Whincup PH. Ischaemic heart disease: association with haematocrit in the British Regional Heart Study. J Epidemiol Community Health 1994;48: 112-18.
47. Salonen JT, Korpela H, Nyyssönen K, et al. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med 1995;237:161-8.
48. Miller YI, Felikman Y, Shaklai N. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation. Arch Biochem Biophys 1996;326:252-60.
49. Miller YI, Smith A, Morgan WT, et al. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. Biochemistry 1996;35:13112-17.
50. Salonen JT, Ylä-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.